首页 | 本学科首页   官方微博 | 高级检索  
     


Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre,two-cohort,single-arm,open-label,phase 2 trial
Authors:Hussein A Tawbi,Melissa Burgess,Vanessa Bolejack,Brian A Van Tine,Scott M Schuetze,James Hu,Sandra D&#x  Angelo,Steven Attia,Richard F Riedel,Dennis A Priebat,Sujana Movva,Lara E Davis,Scott H Okuno,Damon R Reed,John Crowley,Lisa H Butterfield,Ruth Salazar,Jaime Rodriguez-Canales,Shreyaskumar Patel
Affiliation:1. University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. University of Pittsburgh, Pittsburgh, PA, USA;3. Cancer Research and Biostatistics, Seattle, WA, USA;4. Washington University School of Medicine, St Louis, MO, USA;5. University of Michigan, Ann Arbor, MI, USA;6. University of Southern California, Los Angeles, CA, USA;7. Memorial Sloan Kettering Cancer Center, New York, NY, USA;8. Mayo Clinic, Jacksonville, FL, USA;9. Duke University, Durham, NC, USA;10. Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA;11. Fox Chase Cancer Center, Philadelphia, PA, USA;12. Oregon Health & Science University, Portland, OR, USA;13. Moffitt Cancer Center, Tampa, FL, USA;14. Hofstra Northwell School of Medicine, Hempstead, NY, USA;15. Sarcoma Alliance for Research Through Collaboration, Ann Arbor, MI, USA
Abstract:
Keywords:Correspondence to: Dr Hussein A Tawbi   Department of Melanoma Medical Oncology and Department of Investigational Cancer Therapeutics   University of Texas MD Anderson Cancer Center   Houston   TX 77030   USA
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号